NTRA Natera Inc

Price (delayed)

$91.81

Market cap

$8.07B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.12

Enterprise value

$8.39B

Sector: Healthcare
Industry: Diagnostics & Research

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights

The quick ratio has surged by 68% year-on-year and by 8% since the previous quarter
Natera's gross profit has increased by 47% YoY and by 19% QoQ
NTRA's equity is up by 44% year-on-year but it is down by 23% since the previous quarter
The company's debt has surged by 158% YoY and by 39% QoQ
Natera's net income has plunged by 105% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
87.94M
Market cap
$8.07B
Enterprise value
$8.39B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
21.34
Price to sales (P/S)
17.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.67
Earnings
Revenue
$449.31M
EBIT
-$243.33M
EBITDA
-$225.42M
Free cash flow
-$244.24M
Per share
EPS
-$3.12
Free cash flow per share
-$2.82
Book value per share
$4.3
Revenue per share
$5.18
TBVPS
$10.31
Balance sheet
Total assets
$893.51M
Total liabilities
$521.07M
Debt
$380.33M
Equity
$372.45M
Working capital
$624.43M
Liquidity
Debt to equity
1.02
Current ratio
4.74
Quick ratio
4.44
Net debt/EBITDA
-1.4
Margins
EBITDA margin
-50.2%
Gross margin
49.8%
Net margin
-57.5%
Operating margin
-54.4%
Efficiency
Return on assets
-29.3%
Return on equity
-60.8%
Return on invested capital
-27.2%
Return on capital employed
-33.5%
Return on sales
-54.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
-1.48%
1 week
1.35%
1 month
-14.16%
1 year
102.98%
YTD
-7.75%
QTD
-9.58%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$449.31M
Gross profit
$223.85M
Operating income
-$244.42M
Net income
-$258.23M
Gross margin
49.8%
Net margin
-57.5%
Natera's operating income has shrunk by 105% YoY and by 13% QoQ
Natera's net income has plunged by 105% YoY and by 12% from the previous quarter
NTRA's operating margin has dropped by 50% year-on-year
The company's net margin has shrunk by 50% YoY but it rose by 2.2% QoQ

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
21.34
P/S
17.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.67
The EPS has plunged by 81% YoY and by 10% from the previous quarter
NTRA's equity is up by 44% year-on-year but it is down by 23% since the previous quarter
The stock's P/B is 32% more than its last 4 quarters average of 16.2 but 26% less than its 5-year quarterly average of 28.7
NTRA's price to sales (P/S) is 157% higher than its 5-year quarterly average of 6.9 and 4.2% higher than its last 4 quarters average of 17.0
NTRA's revenue is up by 36% year-on-year and by 15% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROS has plunged by 57% YoY
The ROE has grown by 14% YoY but it has contracted by 4.8% from the previous quarter
The ROA is down by 11% year-on-year
The return on invested capital has increased by 4.9% since the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 71% higher than its total liabilities
NTRA's total liabilities has surged by 74% year-on-year and by 17% since the previous quarter
The current ratio has soared by 69% year-on-year and by 9% since the previous quarter
The company's debt is 2.1% higher than its equity
The company's debt has surged by 158% YoY and by 39% QoQ
The debt to equity has soared by 82% from the previous quarter and by 79% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.